7362-39-2
Chemical Structure
p-Coumaric Acid Ethyl Ester
Synonym(s): Ethyl (E)-p-hydroxycinnamate; Ethyl trans-4-hydroxycinnamate
- CAS No.: 7362-39-2
- Formula:C11H12O3
- Molecular Weight:192.21
IUPAC Name: ethyl (E)-3-(4-hydroxyphenyl)acrylate
InChIKey: ZOQCEVXVQCPESC-VMPITWQZSA-N
SMILES: CCOC(/C=C/C1=CC=C(O)C=C1)=O
Biological Activity: p-Coumaric Acid Ethyl Ester (Ethyl (E)-p-hydroxycinnamate; Ethyl trans-4-hydroxycinnamate) is a non-competitive, reversible inhibitor of tyrosinase (IC50=4.89 μg/mL, Ki=1.83 μg/mL), which can quench the intrinsic fluorescence of the enzyme. p-Coumaric Acid Ethyl Ester changes the binding affinity of L-tyrosine by inducing conformational changes in the catalytic domain of tyrosinase, and does not bind to the copper ion of the enzyme. p-Coumaric Acid Ethyl Ester is used in the development of medicines, cosmetics and fruit preservation products using pollen[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
p-Coumaric Acid Ethyl Ester | 99.19% | p-Coumaric Acid Ethyl Ester (Ethyl (E)-p-hydroxycinnamate; Ethyl trans-4-hydroxycinnamate) is a non-competitive, reversible inhibitor of tyrosinase (IC50=4.89 μg/mL, Ki=1.83 μg/mL), which can quench the intrinsic fluorescence of the enzyme. p-Coumaric Acid Ethyl Ester changes the binding affinity of L-tyrosine by inducing conformational changes in the catalytic domain of tyrosinase, and does not bind to the copper ion of the enzyme. p-Coumaric Acid Ethyl Ester is used in the development of medicines, cosmetics and fruit preservation products using pollen. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
p-Coumaric Acid Ethyl Ester (Standard) | ≥98% | Benazeprilat (Standard) is the analytical standard of Benazeprilat. This product is intended for research and analytical applications. Benazeprilat is an orally active and the active metabolite of benazepril, a carboxyl-containing ACE inhibitor with antihypertensive activity. Benazepril is a well-established antihypertensive agent, both in monoresearch and in combination with other classes of drugs including thiazide diuretics and calcium channel blockers. Benazepril is a first-line research in reducing various pathologies associated with CV risk and secondary end-organ damage. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
